Greenwood Capital Associates LLC Invests $6.81 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Greenwood Capital Associates LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 12,932 shares of the healthcare conglomerate’s stock, valued at approximately $6,808,000.

A number of other large investors have also recently made changes to their positions in the stock. Texas Capital Bancshares Inc TX boosted its position in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares in the last quarter. Tealwood Asset Management Inc. raised its holdings in UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares in the last quarter. Atlas Private Wealth Advisors boosted its holdings in shares of UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares in the last quarter. Prentice Wealth Management LLC raised its stake in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares in the last quarter. Finally, Baker Avenue Asset Management LP boosted its stake in UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after acquiring an additional 20 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. TD Cowen lowered their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Robert W. Baird initiated coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 target price on the stock. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a research report on Wednesday, June 5th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Down 0.0 %

UNH traded down $0.18 during trading on Friday, hitting $497.12. The company had a trading volume of 3,188,374 shares, compared to its average volume of 3,452,273. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a market cap of $457.54 billion, a PE ratio of 30.39, a P/E/G ratio of 1.44 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50-day moving average of $493.55 and a 200-day moving average of $505.93.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period last year, the firm earned $6.26 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be paid a $2.10 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. UnitedHealth Group’s payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.